Loading…
Based on limited metadata, Thibiant International, Inc. received an FDA Warning Letter on March 6, 2019, regarding drug products. Without access to the full warning letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided.